1. Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
   Amy Kwan et al, 2021, Viruses CrossRef
2. Teserpaturev/G47Δ: First Approval
   James E. Frampton, 2022, BioDrugs CrossRef
3. Microbial Therapy and Breast Cancer Management: Exploring Mechanisms, Clinical Efficacy, and Integration within the One Health Approach
   Charalampos Filippou et al, 2024, International Journal of Molecular Sciences CrossRef
4. Therapeutic potency of oncolytic virotherapy in breast cancer targeting, current status and perspective
   Safieh Ebrahimi et al, 2019, Journal of Cellular Biochemistry CrossRef
5. Gene therapy: A promising approach for breast cancer treatment
   Niloufar Tavakoli Dastjerd et al, 2022, Cell Biochemistry and Function CrossRef
6. Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?
   Maryam Sadri et al, 2023, International Immunopharmacology CrossRef
7. Programmed cell death: the battlefield between the host and alpha-herpesviruses and a potential avenue for cancer treatment
   Chuankuo Zhao et al, 2018, Oncotarget CrossRef
8. Cancer Immunotherapies and Humanized Mouse Drug Testing Platforms
   Qingfeng Chen et al, 2019, Translational Oncology CrossRef
9. Tumor Ecosystem-Directed Therapeutic Strategies
   Phei Er Saw et al, 2023, Tumor Ecosystem CrossRef